Michael R. Hamblin
Wellman Center for Photomedicine, Massachusetts General Hospital, 40 Blossom St., USA
Michael Hamblin is a Principal Investigator at the Wellman Center for Photomedicine at Massachusetts General Hospital, an Associate Professor of Dermatology at Harvard Medical School and a member of the Affiliated Faculty of Harvard-MIT Division of Health Science and Technology. He was trained as a synthetic organic chemist and received his PhD from Trent University in England. He joined Wellman Labs in 1994. He worked initially in targeted photodynamic therapy (PDT) and prepared and studied conjugates between photosensitizers and antibodies or targeted proteins and polymers of varying charge.
Nanotechnology, Nanobiotechnology, Nanocomposites, Nanobiopharmaceutics, Nanoelectronics, Nanomedicine, Nanotoxicology, Nanoengineering, Nanofabrications, Nanofluidics, Nanohedron, Nanocars, Nanothermite, Nanotubes, Supramolecule, Nanoionics, Nanolithography, Nanoparticles, Bionanoscience